1.
S Amadori, S Suciu, R Willemze, F Mandelli, D Selleslag, R Stauder, A Ho, C Denzlinger, G Leone, P Fabris, P Muus, M Vignetti, A Hagemeijer, F Beeldens, O Anak, T De Witte, EORTC leukemia group, GIMEMA leukemia group. Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. haematol [Internet]. 2004Aug.1 [cited 2024Apr.20];89(8):950-6. Available from: https://haematologica.org/article/view/3191